| Cutting edge: Piezo1 mechanosensors optimize human T cell activation CSC Liu, D Raychaudhuri, B Paul, Y Chakrabarty, AR Ghosh, ... The Journal of Immunology 200 (4), 1255-1260, 2018 | 124 | 2018 |
| Lactate induces pro-tumor reprogramming in intratumoral plasmacytoid dendritic cells D Raychaudhuri, R Bhattacharya, BP Sinha, CSC Liu, AR Ghosh, ... Frontiers in immunology 10, 1878, 2019 | 101 | 2019 |
| Adipose recruitment and activation of plasmacytoid dendritic cells fuel metaflammation AR Ghosh, R Bhattacharya, S Bhattacharya, T Nargis, O Rahaman, ... Diabetes 65 (11), 3440-3452, 2016 | 97 | 2016 |
| Endocannabinoids in immune regulation and immunopathologies O Rahaman, D Ganguly Immunology 164 (2), 242-252, 2021 | 43 | 2021 |
| The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response B Liu, J Huang, A Ashraf, O Rahaman, J Lou, L Wang, P Cai, J Wen, ... Nature Communications 12 (1), 4105, 2021 | 20 | 2021 |
| Cutting edge: dysregulated endocannabinoid-rheostat for plasmacytoid dendritic cell activation in a systemic lupus endophenotype O Rahaman, R Bhattacharya, CSC Liu, D Raychaudhuri, AR Ghosh, ... The Journal of Immunology 202 (6), 1674-1679, 2019 | 16 | 2019 |
| Activity-guided development of potent and selective toll-like receptor 9 antagonists B Paul, O Rahaman, S Roy, S Pal, S Satish, A Mukherjee, AR Ghosh, ... European Journal of Medicinal Chemistry 159, 187-205, 2018 | 16 | 2018 |
| Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism S Roy, A Mukherjee, B Paul, O Rahaman, S Roy, G Maithri, B Ramya, ... European Journal of Medicinal Chemistry 134, 334-347, 2017 | 14 | 2017 |
| Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations S Pal, B Paul, P Bandopadhyay, N Preethy, D Sarkar, O Rahaman, ... European Journal of Medicinal Chemistry 210, 112978, 2021 | 9 | 2021 |
| Development, optimization, and in vivo validation of new imidazopyridine chemotypes as dual TLR7/TLR9 antagonists through activity-directed sequential incorporation of relevant … N Das, P Bandopadhyay, S Roy, BP Sinha, UG Dastidar, O Rahaman, ... Journal of Medicinal Chemistry 65 (17), 11607-11632, 2022 | 7 | 2022 |
| Lactate induces pro-tumor reprogramming in intratumoral plasmacytoid dendritic cells. Front Immunol 10: 1878 D Raychaudhuri, R Bhattacharya, BP Sinha, CSC Liu, AR Ghosh, ... | 5 | 1878 |
| Blocking toll-like receptor 9 signaling with small molecule antagonist A Talukdar, D Ganguly, B Paul, A Mukherjee, ROY Shounak, S Roy, ... US Patent 10,662,177, 2020 | 4 | 2020 |
| Mitigating hERG Liability of Toll‐Like Receptor 9 and 7 Antagonists through Structure‐Based Design N Das, D Bhattacharya, P Bandopadhyay, UG Dastidar, B Paul, ... ChemMedChem 18 (12), e202300069, 2023 | 3 | 2023 |
| Purine based compounds as toll-like receptor 9 antagonist A Talukdar, D Ganguly, A Mukherjee, B Paul, O Rahaman, B Kundu, ... US Patent 11,168,084, 2021 | 3 | 2021 |
| Role of Ca2+ in toll-like receptor 9 activation in human plasmacytoid dendritic cells D Raychaudhuri, P Duttagupta, CSC Liu, J Sarif, AR Ghosh, O Rahaman, ... Cytokine 125, 154822, 2020 | 3 | 2020 |
